Pivotal trial of reovirus in patients with locoregionally recurrent or distally metastatic squamous cell carcinoma of the head and neck.
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2012
At a glance
- Drugs Pelareorep (Primary)
- Indications Head and neck cancer
- Focus Registrational; Therapeutic Use
- 08 Oct 2012 New trial record